• SYNAPS Dx opens lab to support launch of minimally invasive AD diagnostic test

    1 month ago - By Healio

    SYNAPS Dx has announced the opening of a new laboratory to support the launch of DISCERN, a minimally invasive diagnostic test to identify Alzheimer's disease in people with dementia.
    According to a company release, the laboratory is located at the Greencourt Innovation Center in North Bethesda, Md., and will serve as the hub for the research, development and eventual commercialization of the test.
    DISCERN supports a clinician's diagnosis of AD by analyzing factors related to the formation of synaptic connections in the brain that impact memory loss and cognition, as well as
    Read more ...